MAP1LC3A and non-small cell lung carcinoma: The analysis of 27 non-small cell lung cancer cases, stained with double immunohistochemistry for LC3A and HLA-class-I, showed that the LC3A+/HLA+ cancer cell population was by far less conspicuous compared to the ones with the other three expression patterns (p < 0.01; Figure 4a).